ArticleThe Journal of clinical investigation2023

Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.

Raman Devarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.